These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28277046)

  • 1. Social disparities in diabetes care: a general population study in Denmark.
    Heltberg A; Andersen JS; Kragstrup J; Siersma V; Sandholdt H; Ellervik C
    Scand J Prim Health Care; 2017 Mar; 35(1):54-63. PubMed ID: 28277046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic position and cardiovascular risk factors among people with screen-detected Type 2 DM: six-year follow-up of the ADDITION-Denmark trial.
    Dalsgaard EM; Vestergaard M; Skriver MV; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Prim Care Diabetes; 2014 Dec; 8(4):322-9. PubMed ID: 24613817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between socioeconomic deprivation and metabolic/cardiovascular risk factors in a cohort of patients with type 2 diabetes mellitus.
    O'Kane MJ; McMenamin M; Bunting BP; Moore A; Coates VE
    Prim Care Diabetes; 2010 Dec; 4(4):241-9. PubMed ID: 20869343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of small-area-based socioeconomic characteristics in assessing the treatment outcomes of type 2 diabetes patients: a register-based mixed-effect study.
    Toivakka M; Pihlapuro A; Tykkyläinen M; Mehtätalo L; Laatikainen T
    BMC Public Health; 2018 Nov; 18(1):1258. PubMed ID: 30428885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality measure attainment in patients with type 2 diabetes mellitus.
    Lafeuille MH; Grittner AM; Gravel J; Bailey RA; Martin S; Garber L; Sheng Duh M; Lefebvre P
    Am J Manag Care; 2014 Jan; 20(1 Suppl):s5-15. PubMed ID: 24512194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent effects of socioeconomic and psychological social determinants of health on self-care and outcomes in Type 2 diabetes.
    Walker RJ; Gebregziabher M; Martin-Harris B; Egede LE
    Gen Hosp Psychiatry; 2014; 36(6):662-8. PubMed ID: 25103544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between socioeconomic status and metabolic control and diabetes complications: a cross-sectional nationwide study in Chinese adults with type 2 diabetes mellitus.
    Tao X; Li J; Zhu X; Zhao B; Sun J; Ji L; Hu D; Pan C; Huang Y; Jiang S; Feng Q; Jiang C;
    Cardiovasc Diabetol; 2016 Apr; 15():61. PubMed ID: 27048217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic inequalities in cardiometabolic control in patients with type 2 diabetes.
    Ibáñez B; Galbete A; Goñi MJ; Forga L; Arnedo L; Aizpuru F; Librero J; Lecea O; Cambra K
    BMC Public Health; 2018 Mar; 18(1):408. PubMed ID: 29587788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
    Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
    PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Achievement of cardiovascular goals in patients diagnosed with type 2 diabetes with and without cardiovascular disease].
    Garzón G; Gil Á; Herrero AM; Jiménez F; Cerezo MJ; Domínguez C
    Gac Sanit; 2015; 29(6):425-30. PubMed ID: 26342408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in cardiovascular risk factors in incident diabetes.
    Schroeder EB; Bayliss EA; Daugherty SL; Steiner JF
    Womens Health Issues; 2014; 24(1):e61-8. PubMed ID: 24439948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication adherence, biological and lifestyle risk factors in patients with myocardial infarction: a ten-year follow-up on socially differentiated cardiac rehabilitation.
    Hald K; Larsen FB; Nielsen KM; Meillier LK; Johansen MB; Larsen ML; Christensen B; Nielsen CV
    Scand J Prim Health Care; 2019 Jun; 37(2):182-190. PubMed ID: 31122102
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
    Safai N; Carstensen B; Vestergaard H; Ridderstråle M
    BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of social and other determinants of health in the effect of a multicomponent integrated care strategy on type 2 diabetes mellitus.
    Silva-Tinoco R; Cuatecontzi-Xochitiotzi T; De la Torre-Saldaña V; León-García E; Serna-Alvarado J; Guzmán-Olvera E; Cabrera D; Gay JG; Prada D
    Int J Equity Health; 2020 May; 19(1):75. PubMed ID: 32448267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing variability in compliance with recommendations given by the International Diabetes Federation (IDF) for patients with type 2 diabetes in primary care using electronic records. The APNA study.
    Brugos-Larumbe A; Aldaz-Herce P; Guillen-Grima F; Garjón-Parra FJ; Bartolomé-Resano FJ; Arizaleta-Beloqui MT; Pérez-Ciordia I; Fernández-Navascués AM; Lerena-Rivas MJ; Berjón-Reyero J; Jusué-Rípodas L; Aguinaga-Ontoso I
    Prim Care Diabetes; 2018 Feb; 12(1):34-44. PubMed ID: 28732655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Rutten GE
    Br J Gen Pract; 2009 Jan; 59(558):43-8. PubMed ID: 19105915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
    Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
    Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.